Results

Total Results: 376 records

Showing results for "renal".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - December 2007 regarding the possible association of the use of pamidronate with deterioration of renal … • Renal function: m Evidence is insufficient from trials assessing the effect of renal function … Two trials report no effect of renal function on the effects of these agents. … However, in a third trial, impaired renal function reduced the efficacy of zoledronic acid in preventing … Insufficient Evidence is inconclusive on the effects of renal function on the efficacy of alendronate
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
    March 01, 2011 - of antidiabetic drugs 2 Metformin is also frequently avoided in older adults due to declines in renal … sulfonylurea use in older adults is associated with increased risk of hypoglycemia also due to decreasing renal
  3. effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
    February 01, 2021 - or conditions (e.g., advanced heart failure, chronic obstructive pulmonary disease, or end- stage renal
  4. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - other musculoskeletal pain, neuropathic pain, postsurgical pain, dental pain, pain associated with renal … for several acute pain conditions including postoperative pain, dental pain, neck pain, back pain, renal … of systematic reviews include postoperative postdischarge pain, acute back pain, acute neck pain, renal … a new systematic review: pain associated with dental procedures and oral surgery, low back pain, renal … Evidence Gaps Study Populations • Updated comprehensive assessment of the evidence related to renal
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
    January 01, 2011 - Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal … Reticulocyte indices in patients with end stage renal disease on hemodialysis. … Contribution of iron deficiency to anemia in chronic renal failure. … to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal … Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - be idiopathic or primary RLS, or secondary to other conditions such as iron deficiency, end-stage renal … (age, gender, race, comorbidities, disease severity, etiology, iron status, pregnancy, end-stage renal … Studies that include individuals with RLS comorbid with iron deficiency, pregnancy, or end-stage renal
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
    January 01, 2016 - regulation; medication adherence; or self- monitoring for diabetic complications (foot exam, eye exam, and renal
  8. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
    August 01, 2022 - found that the incidence of bone metastases in individuals with prostate cancer, breast cancer, and renal … with bone metastases, the incidence of bone metastasis in individuals with prostate, breast, and renal … with bone metastases, the incidence of bone metastasis in individuals with prostate, breast, and renal
  9. Siminoff_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
    January 01, 2012 - .”  The most common concern of physicians treating diabetes is “renal  failure.”
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
    October 01, 2018 - was no difference between IOCM and LOCM for secondary outcomes, such as cardiac events, need for renal … Main Outcomes: • contrast-induced nephropathy (CIN) • Secondary outcomes: patient characteristics (renal
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - (Hoffmann-La Roche) IL-2 Prophylaxis of acute organ rejection in patients receiving renal transplants … Adjunct for the prevention of rejection in renal homotransplantation; management of active rheumatoid … (Hoffmann-La Roche) Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - shares similar risk factors: male gender, age, diabetes, smoking, hypertension, high cholesterol, and renal … Subgroups reported included age (three studies), symptom class (three studies), renal failure (two studies … from the observational studies had a high likelihood of bias but did show that with advanced age, renal … two RCTs, four observational) in the mixed IC-CLI population reported harms of bleeding, infection, renal … An observational study showed worse survival in advanced age, renal failure, and with higher PAD severity
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - www.effectivehealthcare.ahrq.gov Published Online: November 9, 2011  Interventions to prevent contrast-induced renal
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
    August 23, 2013 - risk prediction tools, including testing and validating the use of newer clinical markers (such as renal … ) medication and procedural interventions in specific subpopulations (e.g., patients with advanced renal … Peer Reviewer #2 ES (Results) The final bullet on page ES-17 states: “Patients with renal impairment … This finding is based on one study of patients with renal impairment, two studies of patients with … Recommendation: Include a separate key point for patients with renal impairment, and specify that these
  15. Ced -Appendix-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    May 29, 2025 - unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal … unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … evidence summary does not include information on the potential contraindications of acamprosate (severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
    October 03, 2019 - health requirements (e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal … and general health (e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Toxicity was more likely with MTX in patients with greater renal impairment. … New Evidence: Those with highrisk comorbidities (cardiovascular events, diabetes, malignancies, renal
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Toxicity was more likely with MTX in patients with greater renal impairment. … New Evidence: Those with highrisk comorbidities (cardiovascular events, diabetes, malignancies, renal
  20. effectivehealthcare.ahrq.gov/products/nephropathy-contrast-induced/research-protocol

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: